RCKT as of Oct 31 · 14:52 ET
RCKTNasdaqPharmaceutical Preparations
Rocket Pharmaceuticals, Inc. · Brief
Next report
5 days
Nov 5 · after closeest.Q3 FY26
Expected move
Inputs0 of 8≥ implied
- avg implied
- ±22.4%
- avg realized
- ±3.4%
Nov 7 '24±26.3%▲+1.16%×0.04
Feb 27 '25±22.3%▲+0.53%×0.02
May 8 '25±16.5%▼−0.71%×0.04
Aug 7 '25±16.7%▼−7.44%×0.45
Q3 FY25±24.5%▼−1.86%×0.08
Q1 FY26±17.9%▲+10.60%×0.59
May 7 '26±25.4%▼−1.09%×0.04
Q2 FY26±29.1%▼−3.85%×0.13
quarterimplied−30%0+30%realized×
Q2 FY26±29.1%▼−3.85%×0.13
May '26±25.4%▼−1.09%×0.04
Q1 FY26±17.9%▲+10.60%×0.59
Q3 FY25±24.5%▼−1.86%×0.08
Aug '25±16.7%▼−7.44%×0.45
May '25±16.5%▼−0.71%×0.04
2 older reports
Feb '25±22.3%▲+0.53%×0.02
Nov '24±26.3%▲+1.16%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · est.Bull2 of 3
Bear2
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
RCKT report sessionNo linked exposure.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.